MONTGOMERY, Texas--(BUSINESS WIRE)--Jan. 17, 2006--Endovasc, Inc. - (OTCBB: EVSC) a Business Development Company focused on acquiring and investing in innovative drug development in the areas of cardiovascular and metabolic medicine, announces results from the Company’s Annual Meeting of Stockholders held on January 13, 2006. As earlier announced, the Company is pleased to report that four of the five main issues proposed by the Board of Directors received shareholder approval. At the Annual Meeting, shareholders in attendance and shareholders through proxy votes, reelected Barbara J. Richardson for an additional three-year term, approved the selection of the Company’s independent registered public accounting firm, approved the amendment to the Company’s Articles of Incorporation to increase the number of authorized Common Stock shares, and voted in favor of the Company’s 2005 Executive Compensation Plan.
